Decitabine improves response rate and prolongs progression‐free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO‐016 trial. Issue 5 (24th February 2018) - Wierzbowska, Agnieszka; Wawrzyniak, Ewa; Pluta, Agnieszka; Robak, Tadeusz; Mazur, Grzegorz J.; Dmoszynska, Anna; Cermak, Jaroslav; Oriol, Albert; Lysak, Daniel; Arthur, Chris; Doyle, Margaret; Xiu, Liang; et al.